By Sharon Zhang, Truthout

A new analysis by Public Citizen found that the U.S. is spending nearly double what the rest of the world spends combined for key drugs. The report offers further evidence that the country is in dire need of pharmaceutical drug price reformation, which progressives are fighting for through the Build Back Better Act.

The report finds that, for the 20 top-selling drugs worldwide, U.S. sales totaled $101.1 billion, while sales of the same drugs to the rest of the world totaled almost $57 billion in 2020. For 11 of the drugs, revenue in the U.S. was double that of the rest of the world combined. And for 11 of the 13 pharmaceutical companies that sell these drugs, U.S. profits made up most of their revenue.

Read More